Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Oct 12;16(10):e0258406. doi: 10.1371/journal.pone.0258406

Effectiveness of community-based health education and home support program to reduce blood pressure among patients with uncontrolled hypertension in Nepal: A cluster-randomized trial

Mahesh Kumar Khanal 1,*, Pratiksha Bhandari 2, Raja Ram Dhungana 3, Pratik Bhandari 4, Lal B Rawal 5,6,7, Yadav Gurung 8, K N Paudel 9, Amit Singh 9, Surya Devkota 10, Barbora de Courten 11
Editor: Yoshihiro Fukumoto12
PMCID: PMC8509872  PMID: 34637478

Abstract

Background

Hypertension is a major global public health problem. Elevated blood pressure can cause cardiovascular and kidney diseases. We assessed the effectiveness of health education sessions and home support programs in reducing blood pressure among patients with uncontrolled hypertension in a suburban community of Nepal.

Methods

We conducted a community-based, open-level, parallel-group, cluster randomized controlled trial in Birendranagar municipality of Surkhet, Nepal. We randomly assigned four clusters (wards) into intervention and control arms. We provided four health education sessions, frequent home and usual care for intervention groups over six months. The participants of the control arm received only usual care from health facilities. The primary outcome of this study was the proportion of controlled systolic blood pressure (SBP). The analysis included all participants who completed follow-up at six months.

Results

125 participants were assigned to either the intervention (n = 63) or the control (n = 62) group. Of them, 60 participants in each group completed six months follow-up. The proportion of controlled SBP was significantly higher among the intervention participants compared to the control (58.3% vs. 40%). Odds ratio of this was 2.1 with 95% CI: 1.01–4.35 (p = 0.046) and that of controlled diastolic blood pressure (DBP) was 1.31 (0.63–2.72) (p = 0.600). The mean change (follow-up minus baseline) in SBP was significantly higher in the intervention than in the usual care (-18.7 mmHg vs. -11.2 mmHg, p = 0.041). Such mean change of DBP was also higher in the intervention (-10.95 mmHg vs. -5.53 mmHg, p = 0.065). The knowledge score on hypertension improved by 2.38 (SD 2.4) in the intervention arm, which was significantly different from that of the control group, 0.13 (1.8) (p<0.001).

Conclusions

Multiple health education sessions complemented by frequent household visits by health volunteers can effectively improve knowledge on hypertension and reduce blood pressure among uncontrolled hypertensive patients at the community level in Nepal.

Trial registration

ClinicalTrial.gov: NCT02981251

Introduction

Hypertension is one of the leading causes of cardiovascular diseases, kidney diseases, and premature death worldwide, increasingly affecting developing countries [1]. It was estimated that 1.13 billion people had hypertension in 2015 worldwide, the majority of them were in low-and middle-income countries [1]. In 2019, high SBP accounted for 10.8 million deaths [2]. Hypertension is responsible for 50% of deaths due to cardiovascular disease (CVD) worldwide [3], including 45% of death due to heart disease and 51% of death due to stroke [4].

The prevalence of hypertension is increasing in developing countries such as Nepal. From 2007 to 2013, the prevalence of hypertension increased from 18.1% to 25.2% [5, 6]. Similarly, a recent meta-analysis conducted by Dhungana et al. identifies an increase in hypertension by 6% over the past 20 years since the year 2000 [7]. Despite the increasing trend of hypertension, only about 4–8% of hypertensive patients have well-controlled blood pressure [5, 8]. Data revealed that blood pressure was normalized only in 3% of patients, over the last five years [7].

Evidence suggests that an alteration and adherence to smoking cessation, reduction to alcohol and salt intake, increased physical activity, and healthy nutrition intake with the abundance of fruits and vegetables [3] and the regular use of antihypertensive drugs can control blood pressure [9]. There are several interventions to improve patient’s adherence to this healthy behavior. One of the effective strategies is behavior counselling or patient education that augments disease perception, motivation, and the ability to adhere to healthy habits [10]. A wealth of literature is available on the effectiveness of health education for blood pressure reduction among patients with hypertension [9, 11, 12]. Most of the studies are conducted in high-income countries. However, there is a paucity of information regarding the effect of health education on blood pressure in low-and middle-income countries like Nepal. Therefore, we aimed to assess the effectiveness of health education combined with frequent home visits in controlling blood pressure among uncontrolled hypertensive patients of the suburban community of Surkhet district of Nepal.

Methods

Study design and site

We conducted a community-based, parallel-group design, open-level, clustered randomized controlled trial in Birendranagar municipality of Surkhet district, Nepal. We considered a ward, the smallest administrative unit of the municipality, as a cluster and a unit of randomization. We used clustered randomization to avoid contamination between the groups. This study was conducted from January 2016 to August 2017. The intervention took place between February and July 2017.

The study site lies about 2500 feet above sea level and 600 kilometres west of the capital city of Nepal, Kathmandu. The total population of the city was 52,137 during the study and people were residing in 12 wards. All wards were inhabited by a multicultural, multiethnic, indigenous, and migrated population [13].

Study participants

Initially, we conducted a cross-sectional study to screen the eligible participants from four clusters. The study method has been followed as described by Khanal et. al. [8]. This trial included people aged 30 years and above, those who had uncontrolled hypertension (SBP ≥140 mm Hg, and/or DBP ≥90 mm Hg) including participants on antihypertensive medication. The familiarity of Nepali language, availability of contact number, residing in the city for at least six months following the baseline data collection, and willingness to participate were other criteria of selection. We excluded the pregnant women, visually impaired or person with hearing loss, any bed-ridden patients, participants diagnosed with kidney disease, cancer, heart disease, chronic obstructive pulmonary disease, and mental illness.

Randomization and study procedure

Initially, we identified eligible participants using a cluster sampling technique. Wards of municipalities were regarded as a cluster. From the twelve wards of the municipality, thirty percent of the wards (four wards) were chosen randomly. After the completion of participant recruitment, baseline data collection and obtaining informed consent in those four clusters, we performed randomization of clusters. A statistician, without previous knowledge of clusters, randomly assigned (1:1) four clusters to intervention and control groups, using computer-generated codes. We conducted a follow-up data collection after six months from patients of intervention and control groups using the same tool as in baseline. Separate enumerators involved in the final phase who were blinded to intervention and control group.

Sample size

In our protocol, we aimed for a total sample size of 76 (38 from each cluster) in each arm of the trial with alfa = 0.05, beta = 0.20 and a non-response rate of 15% [14]. It was estimated based on the fact that normalized blood pressure can be achieved in 25% of uncontrolled hypertensive patients after health education while only 5.2% of patients achieve controlled blood pressure through usual care [15]. After the literature review, we used an inter-cluster correlation (ICC) = 0.01 for community-based hypertension trial to adjust for the design effect [16]. During the implementation of the research, we managed to randomize a total of 125 participants in either arm. As only 120 participants completed the trial, in the main analysis, we could analyze data of those who were followed up. However, we analyzed information of 125 samples in the sensitivity analysis by incorporating imputed missing values.

Outcomes of the study

The primary outcome of the study was the proportion of hypertensive patients with normalized SBP in the intervention and the control group. The secondary outcomes were the proportion of controlled DBP, mean difference of SBP, DBP, body mass index (BMI), waist circumference (WC), and knowledge score after six months of intervention and usual care.

Blood pressure measurements

We had provided robust training to enumerators to measure the blood pressure using an aneroid sphygmomanometer on the left arm. Based on the upper arm circumference of the participant, we used an appropriate cuff size. For accuracy, we had recorded two readings of every participant, first after 15 minutes of rest in the uncrossed leg and second after three minutes of the first measurement. The mean of two readings was used for the final analysis [17, 18].

Hypertension control

Hypertension was defined as average SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or history of taking antihypertensive medication in the last two weeks [17]. Controlled SBP was defined as SBP < 140 mmHg and controlled DBP was defined as DBP < 90 mmHg among hypertensive participants [19]. Finally, if both systolic and diastolic BP was below these levels, we defined them as controlled blood pressure.

Variables related to behavior

We defined current smokers as those who were smoking cigarettes and who quit less than one month before the interview. Respondents who were chewing tobacco in the last 30 days were defined as current tobacco users [18]. We called respondents as current alcohol user if they had drunk alcohol within the last 30 days of data collection. We had shown a pictogram to estimate the number of servings of fruit and vegetable intake in a week. Fruit and vegetable intake of at least 400 grams or at least five servings per day was considered as sufficient fruit and vegetable consumption [18]. We used the Global Physical Activity Questionnaire (GPAQ), adapted from Stepwise Approach to Surveillance (STEPS survey) Nepal, to assess the physical activity level. We calculated the amount of physical activities in metabolic equivalents of task (MET) per minute per week based on STEPS questionnaires. We used a cut-off value of 600 MET-minutes per week or lower to define inadequate level (physically less active) [18].

Anthropometric measurements

We used a portable stadiometer and weighing machine, respectively to measure height and weight. We used a tape to measure the waist circumference at the mid-point between the lower margin of the last palpable rib and the top of the iliac crest (hip bone) at the end of a normal expiration, holding the arms relaxed at the sides. The BMI was classified as underweight (<18.5 Kg/m2), normal (18.5–24.9 Kg/m2), overweight (≥25 Kg/m2), and obese (≥30 Kg/m2) [20]. Central obesity was defined as an increased waist circumference of more than 88 cm in women and more than 102 cm in men [21].

Interventions

The participants in the intervention group received group-based interactive health education sessions, followed by home visits by community health volunteers, and locally available standard care. The detail of the interventions is provided as below:

Interactive health education sessions

One medical graduate and one registered nurse facilitated four health education sessions during the six months intervention period. Those sessions were conducted at first, second, third and fifth months after the enrolment of the participants. In each session, about 15–20 participants attended the discussion for about two hours. Sessions were based on a specific syllabus (S1 Table). We designed the syllabus based on the patient information of the American Heart Association [22], the seventh report of the joint National Committee on Prevention, Detection, evaluation, and treatment of high blood pressure [17], the National Health Education Information and Communication Centre of Nepal [23], and World Health Organization (WHO) pocket guidelines for assessment and management of cardiovascular risk [24].

The health education syllabus is comprised of seven chapters: (1) communication, (2) introduction to hypertension, (3) causes/factors associated with hypertension and (4) complications of high blood pressure, (5) lifestyle management, (6) medication for hypertension and (7) WHO/ISH CVD risk prediction chart. In the first session, we discussed the previous knowledge, experiences, barriers, difficulties in changing behavior, taboos and misconception about high blood pressure to get the baseline knowledge and to make a comfortable environment among the participants and facilitator. Then, we focused on the meaning and measurement of blood pressure; grading, burden, causes, and complications of hypertension in detail, and a brief discussion on lifestyle management and antihypertensive medication. In the following sessions, at the outset, we summarized the previous health messages and discussed in detail lifestyle management and medication for high blood pressure.

In lifestyle management, we delivered the health information related to healthy eating, a nutritional recommendation based on Dietary approaches to stop hypertension (DASH), physical activity, maintaining a healthy weight, limit (or avoid) alcohol, quit tobacco, reducing stress, tips for changing daily life in the context of the living condition of the community. Moreover, the facilitators discussed indications of antihypertensive medication, types of medicines, mechanisms to reduce blood pressure, monitoring of blood pressure medication, ways to reduce side effects of medicine, importance and methods of adherence of medicine, and the WHO risk prediction chart.

Home support through health volunteer

At least one community volunteer for each cluster was mobilized for motivating and supporting the participants in the community. We trained the health volunteer on accurate blood pressure measurement and behavior change counselling based on the same syllabus designed for the participants. The health volunteer visited the participant’s home in 15–30 days intervals. The volunteers measured the blood pressure, discussed the problems facing personally or in the family in controlling blood pressure. They reminded about physical activities and fruit and vegetable intake, advised to visit their health professionals if blood pressure was not in the normal range, and provided feedback to the participants and their family members.

Usual care for those in the control arm

The participants of the control group received locally available usual health care. During the time of the intervention, the Birendranagar municipality, Surkhet had one government regional tertiary level hospital, three fifteen-bedded private hospitals, one primary care level health centre, six polyclinics, and one Zonal Ayurveda Hospital. Further, the municipality had a district public health office and some ongoing public health-related programs within the municipality area.

Randomization, study procedure, and follow-up

At first, we identified eligible participants using a cluster sampling technique. Among twelve wards, four wards were selected randomly. After the completion of participant recruitment and baseline data collection in all four clusters, we randomly assigned two clusters in each arm; two with health education and home support and two with usual care groups. We conducted a follow-up data collection after six months from patients of intervention and control groups using the same tool as in baseline. Enumerators of the follow-up stage did not know about baseline information.

Data collection

The first phase of the study was screening for an individual with high blood pressure in each cluster, the detail of this is present everywhere [8]. In brief, trained enumerators collected required data utilizing WHO STEPS questionnaires [18] to gather information related to age, sex, socio-economic status, smoking and tobacco use, alcohol, fruit, vegetable and salt intake, and physical activities. In addition, they recorded the previous diagnosis of hypertension, intake of any anti-hypertensive drugs within two weeks before the data collection. Additionally, we used another tool with ten questionnaires to assess hypertension-related knowledge, where six questionnaires had three multiple-choice answers and four had more than three multiple choice answers. Point one was given for correct answers, zero for incorrect and unanswered questions, whereas half point was allocated for partially correct answers. We developed questionnaires and adapted the scoring criteria based on the steps used by Chu-Hong Lu et al [15]. Before application, two independent translators had translated these tools into the Nepali language and one of the authors finalized the set of questionnaires. We had pre-tested the final versions of all tools among 20 participants before final implementation. These same tools were used for both baseline and follow-up data collection.

Data quality and safety monitoring

We recruited a field supervisor to monitor the intervention. As proof of intervention, we used a register to record the date, time, activities and names of participants who were involved in the group counselling sessions and home visits. These activities were cross-verified by the field supervisor and were confirmed during the follow-up survey by asking participants. This supervisor was responsible for reviewing data quality and report any missing information and errors during data collection. To report any adverse effects of the intervention, we had provided the contact number of the field supervisor and principal investigator to the participants.

Data analysis

We compiled, edited and entered data in Epidata 3.1. We removed duplicates and exported them to SPSS V.20.0 for final analysis. Complete case analysis as per protocol was done for the individual participants who completed the trial. Descriptive statistics (mean, standard deviation for continuous variables and proportion for discrete variables) were used to present the characteristics of the study subjects for both baseline and follow-up stages. Independent t-test (continuous variable) and Chi-square test (binary variable) were used to compare the difference between the groups. Additionally, we used Fischer’s exact test if the expected frequency was small (less than five). A binary logistic regression model was applied with three separate dependent variables in the main analysis. First was presence or absence of normalized SBP at the follow-up. The second was presence or absence of SBP at the end of the trial and lastly as presence or absence of controlled blood pressure (both systolic and diastolic) at follow-up. Then, the models were adjusted for age, gender, level of education, ethnicity, clustering effect, baseline mean blood pressure (SBP for systolic, DBP for diastolic and both for blood pressure), and baseline knowledge score. Additionally, for mean SBP, DBP, knowledge score, BMI and waist circumference, we computed mean (SD) of change (follow-up minus baseline). Box plot was also used to present effect of the intervention on mean SBP and DBP from baseline and follow up in both intervention and control groups. Additionally, we also performed a linear regression analysis of follow-up knowledge score using baseline knowledge score and intervention. In the end, we used Little’s test for MCAR (missing completely at random) test of missing value to perform sensitivity analysis. We applied Expectation-Maximization (EM) imputation technique to impute missing data (5) using baseline and follow-up SBP and DBP of all available participants. All tests were two-tailed and p < 0.05 was considered statistically significant.

Ethical consideration

We obtained ethical approval from the Ethical Review Committee of Nepal Health Research Council (Reg. no. 24/2016, on 17 February 2016). Every participant read the form and provided the written consent either by signature or with a thumb impression if participants could not write. We explained the study aims, data collection procedures, interventions stages and contents, benefits, risks, and confidentiality to every respondent before obtaining consent.

This trial was registered in the clinical trial registry (ClinicalTrial.gov: NCT02981251) on December 5, 2016.

Results

Participants’ flow

In January 2017, we randomly assigned two clusters in the intervention group and two clusters in the control group. A number of participants who received interventions was 63 and those who were on usual care were 62. At six months of intervention, 3 participants either migrated, lost the phone or discontinued on the intervention group and 2 participants were lost to follow-up because of the same reasons in the control arm. As we did not have follow-up data of five participants, we analyzed 60 samples in both intervention and control groups for baseline and characteristics and intervention effect (Fig 1). In the end, we included all randomized participants in the sensitivity analysis. None of the participants reported experiencing any adverse effects due to intervention and nobody reported changes in medication use.

Fig 1. CONSORT 2010 flow diagram of study participants.

Fig 1

Baseline socio-demographic characteristics of the participants

Forty-five percent were male in both control and intervention groups. The mean age was 56.6 years for both arms with standard deviation (SD) of 10.2 and 11.6 years, respectively. Majority in both groups were married, had no formal education and were above the poverty line. In the control group, 36.7% were employed, whereas 45% of the intervention group were household workers. All of the sociodemographic characteristics were similar as all of these were statistically non-significant (Table 1).

Table 1. Baseline socio-demographic characteristics of study participants.

Variable Usual care (n = 60) Intervention (n = 60) P value
n (%) n (%)
Sex
Male 27 (45.0) 27 (45.0) 1.00
Female 33 (55.0) 33 (55.0)
Age (years)
30–44 8 (13.3) 9 (15.0) 0.854
45–59 26 (43.3) 23 (38.3)
≥ 60 26 (43.3) 28 (46.7)
Mean (SD) 56.6 (10.2) 56.6 (11.6) 0.972
Marital status
Unmarried 1 (1.7) 1 (1.7) 0.424*
Married 53 (88.3) 48 (8.0.0)
Single 6 (10.0) 11 (18.3)
Ethnicity
Brahman 17 (28.3) 8 (13.3) 0.157
Kshetri 11 (18.3) 11 (18.3)
Shahi or Thakuri 5 (8.3) 6 (10.0)
Dalit 16 (26.7) 27 (45.0)
Janajati 11 (18.3) 8 (13.3)
Level of education
No formal education 42 (70.0) 39 (65.0) 0.67*
Primary (grade 1–5) 4 (6.7) 8 (13.3)
Secondary (grade 6–10) 9 (15.0) 9 (15.0)
Higher (grade >11) 5 (8.3) 4 (6.7)
Occupation
Employed 22 (36.7) 16 (26.7) 0.478
Household work 19 (31.7) 27 (45.0)
Agriculture or labor 14 (23.3) 13 (21.7)
Unemployed 5 (8.3) 4 (6.7)
Economic status
Above poverty line 49 (81.7) 50 (83.3) 0.81
Poor** 11 (18.3) 10 (16.7)

* Fischer’s exact test,

**If family income per person per year was less than Rupees 16, 355 (US$: 163)

Health behavior and drug intake of participants at baseline

Of the total, 21.7% and 13.3% of participants were current smoker in control and intervention group, respectively. Among these two groups, around one-fifth (21.7%) and one-third (36.7%) were consuming alcohol at the baseline. Most of participants did not consume adequate servings of fruits and vegetable (98% vs. 93%). Participants in the intervention group were less physically active (46.7%) compared to the usual care group (30%). Compared to the control group (53.3%), 40% of participants in the intervention group were taking antihypertensive medicine. All of these health behaviors were statistically non-significant (Table 2).

Table 2. Baseline smoking, alcohol consumption, fruit and vegetable intake, physical activities and drug intake.

Variables Control (n = 60) Intervention (n = 60) P value
n (%) n (%)
Smoking
Yes 13 (21.7) 8 (13.3) 0.476
No 47 (78.4) 52 (86.7)
Alcohol consumption
Yes 13 (21.7) 22 (36.7) 0.071
No 47 (78.3) 38 (63.3)
Inadequate Fruit and Vegetable intake
Yes 59 (98.3) 56 (93.3) 0.171
No 1 (1.7) 4 (6.7)
Level of physical activities
Low 18 (30.0) 28 (46.7) 0.06
Active 42 (70.0) 32 (53.3)
Proportion of hypertension treatment
Yes 32 (53.3) 24 (40.0) 0.143
No 28 (46.7) 36 (60.0)

Effectiveness of intervention

After six months of health education and community support, the proportion of participants with well-controlled SBP increased to 58.3% from 3.3% compared to only to 40% from 3.3% among the usual care group. The intervention had 2.1 times higher odds of having well-controlled blood pressure compared to usual care (p = 0.046), whose 95% confidence interval (CI) was 1.01–4.35. After adjusting for age, sex, ethnicity, education level, clustering effect, baseline knowledge score, the odds increased to 2.94 (CI 1.25–6.9). Similarly, percentage of the controlled DBP increased by 30% after the intervention compared to only 20% on usual care. The unadjusted odds ratio of controlled DBP was 1.31 (0.63–2.72) (p = 0.600). When we adjusted for age, sex, ethnicity, education level, clustering effect, baseline knowledge score, and baseline DBP, the odds ratio (OR) was 1.24 (0.55–2.80). Likewise, 38.3% of participants had well-controlled blood pressure six months after the intervention, whereas only 28.3% of respondents had controlled BP on usual care. The unadjusted odds ratio for controlled BP was 1.57 (0.73–3.38) and the adjusted OR was 1.79 (0.74–4.35) (Table 3).

Table 3. Intervention effects on outcome variables.

Variables Baseline (n = 120) Follow-up (n = 120) Unadjusted Odds Ratio Adjusted Odds Ratio
Control (n = 60), n (%) Intervention (n = 60), n (%) Control (n = 60), n (%) Intervention(n = 60), n (%) OR (95% CI) P value OR (95% CI) P value
Controlled SBP 2 (3.3) 2 (3.3) 24 (40.0) 35 (58.3) 2.1 (1.01–4.35) 0.046 2.94a (1.25–6.9) 0.013
Controlled DBP 11 (18.3) 9 (15.0) 23 (38.3) 27 (45.0) 1.31 (0.63–2.72) 0.459 1.24b (0.55–2.80) 0.600
Controlled BP 0.00 0.00 17 (28.3) 23 (38.3) 1.57 (0.73–3.38) 0.247 1.79c (0.74–4.35) 0.194

a Adjusted for clustering effect, age, sex, ethnicity, level of education, baseline mean SBP and total knowledge score

b Adjusted for clustering effect, age, sex, ethnicity, level of education, baseline mean DBP and total knowledge score

c Adjusted for clustering effect, age, sex, ethnicity, level of education, baseline mean SBP, DBP and total knowledge score

The mean (SD) of SBP was 152.1 (12.9) mmHg and 156.6 (17.4) mmHg in control and intervention groups, respectively. At six months, the mean (SD) of SBP was 140.9 (19.5) mmHg in usual care and 137.8 (17.0) mmHg in intervention. The mean difference in SBP among the intervention group was significantly higher than that in the control group (p<0.041). Similarly, the mean (SD) of DBP was 98.8 (13.2) mmHg in baseline and 93.3 (13.7) mmHg during follow-up in the control group. The mean (SD) of DBP reduced from 100.41 (14.5) mmHg to 89.46 (9.4) mmHg after intervention (Table 4 and Fig 2).

Table 4. Mean blood pressure, body mass index, waist circumference, and knowledge score related to hypertension.

Variables Control (n = 60) Intervention (n = 60) P value (difference of means)
Mean (SD) P value Mean (SD) P value
Systolic Blood Pressure
Baseline 152.1 (12.9) < .001 156.6 (17.4) < .001
Follow-up 140.9 (19.5) 137.8 (17.0)
Change (Follow-up minus baseline) -11.2 (20.1) -18.7 (19.8) 0.041
Diastolic Blood Pressure
Baseline 98.8 (13.2) 0.015 100.41 (14.5) < .001
Follow-up 93.3 (13.7) 89.46 (9.4)
Change (Follow-up minus baseline) -5.53 (17.1) -10.95 (14.6) 0.065
Total Knowledge Score
Baseline 4.05 (1.5) 0.572 4.46 (1.6) < .001
Follow-up 4.1 (1.2) 6.85 (1.8)
Change (Follow-up minus baseline) 0.13 (1.8) 2.38 (2.4) <0.001
Body Mass Index
Baseline 26.13 (3.95) 0.527 24.63 (3.9) 0.011
Follow-up 25.94 (3.9) 23.91 (3.5)
Change (Follow-up minus baseline) -0.18 (2.31) -0.71 (2.1) 0.197
Waist Circumference
Baseline 95.33 (13.6) 0.844 93.43 (11.6) 0.495
Follow-up 95.10 (12.08) 92.70 (11.1)
Change (Follow-up minus baseline) -0.23 (9.1) -0.73 (8.2) 0.754

Fig 2. Box-plot of mean SBP and DBP of intervention and control group.

Fig 2

The average change of SBP (SD) from follow-up to baseline was significantly higher in the intervention group with -18.7 (19.8) mmHg than in the control group at -11.2 (20.1) mmHg (p = 0.041). A similar change in DBP (SD) was -5.53 (17.1) mmHg in usual care and -10.95 (14.6) mmHg after intervention (Table 4 and Fig 2). In a subgroup analysis of gender, mean difference of SBP was significantly higher in the intervention group compared to the control among women (p = 0.01) and age cohort of 45 to 59 years (p = 0.033). Similarly, a difference in DBP was significantly higher in the intervention group among participants aged 60 and above (p = 0.049) (S5 Table).

The total knowledge score (SD) increased from 4.46 (1.6) to 6.85 (1.8) in the intervention group. The mean difference (follow-up minus baseline) of this score was 2.38 (2.4) in the intervention arm, which was significantly higher than that of the control group, 0.13 (1.8) (p<0.001) (Table 4). Linear regression analysis showed knowledge score mean difference rose significantly (S1 Table). The mean change (SD) in BMI (follow-up minus baseline) was -0.18 (2.31) and -0.71 (2.1) in control and intervention, respectively. The mean difference (SD) of waist circumference was -0.23 (9.1) cm in the usual care and -0.73 (8.2) cm in the intervention group (Table 4).

Sensitivity analysis

On sensitivity analysis of all 125 data including imputed missing value, unadjusted odds ratio (95% CI) was 2.1 (1.03–4.29). The intervention was significantly effective (p = 0.041) in controlling SBP, as seen in the main analysis. The odds ratio (95% CI) of controlled DBP and controlled BP were 1.52 (0.75–3.14) and 1.86 (0.87–3.93), respectively. As in the main analysis, these were non-significant. After adjusting for age, sex, clustering effect, ethnicity, level of education, and baseline SBP or DBP, or both, results were almost similar to the main analysis (Table 5).

Table 5. Sensitivity analysis of intervention effects on outcome variables.

Variables Baseline (n = 125) Follow-up (n = 125) Unadjusted Odds Ratio Adjusted Odds Ratio
Control (n = 62) n (%) Intervention (n = 63) n (%) Control (n = 62) n (%) Intervention (n = 63) n (%) OR (95% C.I.) P value OR (95% C.I.) P value
Controlled SBP 2 (3.2) 2 (3.2) 26 (41.9) 38 (60.3) 2.1 (1.03–4.29) 0.041 2.84a (1.26–6.42) 0.012
Controlled DBP 11 (11.7) 10 (15.9) 23 (37.1) 30 (47.6) 1.52 (0.75–3.14) 0.235 1.63b (0.75–3.56) 0.213
Controlled BP 0.00 0.00 17 (27.4) 26 (41.3) 1.86 (0.87–3.93) 0.105 2.26c (0.97–5.23) 0.056

a Adjusted for clustering effect, age, sex, ethnicity, level of education, and baseline mean SBP.

b Adjusted for clustering effect, age, sex, ethnicity, level of education, and baseline mean DBP.

c Adjusted for clustering effect, age, sex, ethnicity, level of education, and baseline mean SBP, DBP.

Discussion

Our study demonstrated that health education related to blood pressure by health professionals in a small group along with community support is effective to attain a normal range of blood pressure in community settings. This study provides evidence that health education and home visits can be used to the existing health systems of low-and-middle-income countries such as Nepal. This helps to maintain satisfactory blood pressure control by increasing knowledge and awareness among patients with hypertension.

Our findings are in line with other similar studies conducted in various settings. One similar cluster randomized controlled trial conducted in rural India reported that three months of health education intervention reduced blood pressure by 20.3% among the intervention group compared to 9.5% among usual care [25]. Another study conducted in Argentina showed that community health worker-led home-based intervention implemented for six months improved the proportion of those with controlled BP from 17.0% at baseline to 45.6% at 6 months in the intervention group compared to 17.6.% at baseline to 40.8% in the control group [26]. Our study also revealed that the change in systolic and diastolic blood pressure (follow-up minus baseline) after health education and home support was higher among the intervention group compared to the control group. Our findings are consistent with that of the COBIN trial [27], a recent community based clustered randomized controlled trial in Nepal. This trial showed that the mean SBP decreased by 6.47 mmHg after one year in the health education and lifestyle intervention group and 2.85 mmHg in the control group and the mean DBP changed by 2.9 mmHg compared to 1.11 mmHg, respectively, among the hypertensive patients [27]. Our results also correspond to the data released by Gamang et. al. [25] from a study in India, which showed the SBP decreased by 8.2 mmHg in health education intervention in comparison to 2.1 mmHg in the control group. DBP was also reduced by 4.2 mmHg and 2.2 mmHg, respectively, in intervention and control groups [25].

Our results also showed that the knowledge score was significantly higher among the participants who received health education. These insights and learning about hypertension might have helped to reduce blood pressure among the intervention group. It can be expected that improved knowledge might significantly affect adherence to healthy lifestyle and regular use of medication. Many studies demonstrated the link between knowledge score and adoption and maintenance of a healthy lifestyle. For instance, one meta-analysis of 13 studies conducted in middle-income countries showed that group education and other supportive methods improved the adherence to lifestyle modification [28]. Similarly, another study revealed group counselling and home visits encourage the participants to adopt healthy self-care practices [29]. Therefore, health education is a tool to improve patient engagement and to begin and maintain adherence to lifestyle modification and compliance with medications [30] which is ultimately one of the strongest tools for the prevention of cardiovascular disease [31]. The long-term consequence of health literacy among patients of chronic illness is that it may prevent co-morbidities [32].

Our study generated evidence of utilizing health education related to blood pressure in our existing health system to control hypertension in low-and-middle-income countries such as Nepal. Nepal is constantly developing its health system. Majority of wards (small administrative units) of urban and rural municipalities have at least one health institution such as health post or urban health clinics [33]. We can mobilize currently existing resources for hypertension and healthy lifestyle education as we had conducted in our study. Group counselling could be conducted for hypertensive patients in those health institutions by currently working health professionals along with community support by Female Community Health Volunteers (FCHV). This can have a significant impact on blood pressure control and benefit on other diseases such as obesity, diabetes and cardiovascular risk factors. Neupane et al. [27] reported that utilizing the existing FCHV of Nepal can significantly reduce blood pressure level in community settings among normotensive, prehypertensive and hypertensive patients. This concept has also been studied in China and India, which found that health belief model-based health education could significantly improve the blood pressure control of hypertensive patients in the community [25, 34].

The current study has several strengths. We believe this to be the first study that conducted both group counselling and frequent home visits for uncontrolled hypertensive patients in community settings of Nepal. This study was unique in its design in Nepal, where we applied clustered randomization assuming whole ward (small administrative unit) as a clustered. Furthermore, we designed the syllabus for the group counselling and explained the study steps in detail to facilitate the replication. Additionally, our study had a comparison with the usual care group for comparison of the effects of intervention. We had also used different data enumerators for baseline and follow-up data collection to minimize the assessor’s bias.

However, our study holds some limitations. At the outset, we could use only a small sample size. This implies the result must be interpreted carefully. Furthermore, as during the first phase of the study, we randomly screened the hypertensive patients only in four clusters [8], we could not increase the number of clusters for the trial. We could not perform the ancillary analysis for the effect of health education on lifestyle modification and antihypertensive drug adherence for these two reasons. In addition, as it was a six-month trial, we could not minimize the seasonal variation of blood pressure by taking blood pressure measurements in the same season [35, 36]. Apart from this, we had provided the syllabus to the medical graduates and registered nurses, but we did not conduct training sessions for them. They taught the participants with the best of their academic knowledge. Because of this, information sharing might have been varied between the groups. Finally, as we conducted our study only in a single municipality, the findings should be cautiously generalized to other settings.

Conclusions

In conclusion, multiple sessions of group health education complemented by frequent household visits by trained health volunteers can effectively improve the hypertension related knowledge and reduce blood pressure among people with uncontrolled hypertension at the community level in Nepal. A large-scale research with a larger sample size is needed to assess whether this approach can be cost-effective and the findings can be generalized for a larger population in Nepal.

Supporting information

S1 Table. Syllabus for health education.

(DOCX)

S2 Table. Linear regression model for change in knowledge score.

(DOCX)

S3 Table. CONSORT extension for cluster trials 2010 checklist.

(DOCX)

S4 Table. Trial protocol.

(DOC)

S5 Table. Distribution of mean difference at 6-month follow-up SBP and DBP by gender, age, in both control and intervention group.

(DOCX)

Acknowledgments

This study was supported by Birendranagar municipality and Bheri Zonal Ayurveda Hospital. The authors want to acknowledge the staff of Bheri Zonal Ayurveda Hospital, Surkhet for providing logistic and managerial support. We cannot forget the help from Batabaran Bhawan and Bhairav Secondary School for providing a venue to conduct health education sessions. Similarly, they would like to express especial thanks to field supervisor and data collector team: Ms. Nirmala, Ms Lata, Mr. Narendra, Mr. Tulsi, Mr. Man Bahadur, Ms.Deepa, Ms. Bishnu, Ms. Debisara, Ms. Laxmi, Ms. Kalpana, Ms. Shamjhana, Ms. Prema, Ms. Chitra, Ms. Sita, Ms. Jwoti, Ms. Shobha, Ms. Ranjana, Ms. Pratiksha, Ms. Amrita, Mr. Deepak. The study team wants to thank Chair Person of ward number 4 of Birendranagar Municipality Mr. Nilkantha Khanal and Female Community Health Volunteers (FCHV) of ward number 4, 5, 8 and 10 for supporting in the community mobilization. In the end, authors want to acknowledge Royal Australasian College of Physicians for supporting Career Development Fellowship to B.d.C.

Data Availability

All data files are available from the Dryad repository, available at https://doi.org/10.5061/dryad.7h44j0zts.

Funding Statement

Nepal Family Development Foundation, Kathmandu, Nepal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Hypertension Fact Sheet [Internet]. 2021 May 20, [Updated 17 May 2017; Cited 21 May 2021] available [https://www.who.int/news-room/fact-sheets/detail/hypertension]
  • 2.Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. : Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2020, 396(10258):1223–1249. doi: 10.1016/S0140-6736(20)30752-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.WHO (2011) Global status report on non communicable disaeses 2010. Geneva: World Health Organization.
  • 4.WHO (2008) Causes of Death. Geneva: World Health Organization.
  • 5.Aryal KN S; Mehata S; Vaidya A; Singh S; Paulin F; Madanlal, et al. : Non communicable diseases risk factors: STEPS Survey Nepal 2013. In. Kathmandu; 2014. [Google Scholar]
  • 6.Ministry of Health and Education GoN, Solid Nepal (2008), WHO STEPS surveillance: Non Communicable Disease Risk Factors Survey. Ministry of Health and Population, Government of Nepal, society for Local Integrated Development Nepal (SOLID Nepal) and WHO.
  • 7.Dhungana RR, Pandey AR, Shrestha N: Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in Nepal between 2000 and 2025: A Systematic Review and Meta-Analysis. International Journal of Hypertension 2021, 2021:6610649. doi: 10.1155/2021/6610649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Khanal MK, Dhungana RR, Bhandari P, Gurung Y, Paudel KN: Prevalence, associated factors, awareness, treatment, and control of hypertension: Findings from a cross sectional study conducted as a part of a community based intervention trial in Surkhet, Mid-western region of Nepal. PloS one 2017, 12(10):e0185806. doi: 10.1371/journal.pone.0185806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fahey T, Schroeder K, Ebrahim S: Interventions used to improve control of blood pressure in patients with hypertension. The Cochrane database of systematic reviews 2006(4):CD005182. doi: 10.1002/14651858.CD005182.pub3 [DOI] [PubMed] [Google Scholar]
  • 10.Beune EJAJ MvCE, Beem L, Mohrs J, Agyemang CO, et al.: Culturally Adapted Hypertension Education (CAHE) to Improve Blood Pressure Control and Treatment Adherence in Patients of African Origin with Uncontrolled Hypertension: Cluster-Randomized Trial. PLoS ONE 9(3): e90103. 2014. doi: 10.1371/journal.pone.0090103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ogedegbe GO, Boutin-Foster C, Wells MT, Allegrante JP, Isen AM, Jobe JB, et al. : A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Archives of internal medicine 2012, 172(4):322–326. doi: 10.1001/archinternmed.2011.1307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hennessy S, Leonard CE, Yang W, Kimmel SE, Townsend RR, Wasserstein AG, et al. : Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial. Pharmacotherapy 2006, 26(9):1342–1347. doi: 10.1592/phco.26.9.1342 [DOI] [PubMed] [Google Scholar]
  • 13.CBS (2014) National Population and Housing Census 2011, vol. 05, First edn. Kathmandu: Central Bureau of Statistics, Nepal.
  • 14.Hemming K, Girling AJ, Sitch AJ, Marsh J, Lilford RJ: Sample size calculations for cluster randomised controlled trials with a fixed number of clusters. BMC Medical Research Methodology 2011, 11:102–102. doi: 10.1186/1471-2288-11-102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lu C-H, Tang S-T, Lei Y-X, Zhang M-Q, Lin W-Q, Ding S-H, et al. : Community-based interventions in hypertensive patients: a comparison of three health education strategies. BMC Public Health 2015, 15(1):33. doi: 10.1186/s12889-015-1401-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ha DA, Tran OT, Nguyen HL, Chiriboga G, Goldberg RJ, Phan VH, et al. : Conquering hypertension in Vietnam—solutions at grassroots level: study protocol of a cluster randomized controlled trial. Trials 2020, 21(1):985. doi: 10.1186/s13063-020-04917-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. : The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289(19):2560–2572. doi: 10.1001/jama.289.19.2560 [DOI] [PubMed] [Google Scholar]
  • 18.WHO (2005) WHO STEPS Surveillance Manual: The WHO STEPwise approach to chronic disease risk factor surveillance / Noncommunicable Diseases and Mental Health. Geneva: World Health Organization.
  • 19.Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. : Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013, 310(9):959–968. doi: 10.1001/jama.2013.184182 [DOI] [PubMed] [Google Scholar]
  • 20.WHO (1997) Preventing and Managing the Global Epidemic of Obesity. Report of the World Health Organization Consultation of Obesity. Geneva: World Health Organization. [PubMed]
  • 21.WHO (2008) Waist circumference and waist–hip ratio: report of a WHO expert consultation. Geneva: World Health Organization.
  • 22.American Heart Association and American Stroke Association: Understanding and Managing High Blood Pressure, Cited May 12, 2021, available at [https://www.ndhealth.gov/chronicdisease/pdf/Understanding_Controlling_Your_High_BP_E-Sample.pdf]
  • 23.NHEICC (2017) Noncommunicable Diseases. Kathmandu: National Health Education Information and Communication Centre.
  • 24.WHO (2007) Prevention of Cardiovascular Diseases: Pocket guidelines for assessment and management of cardiovascular risk. Geneva: World Health Organization.
  • 25.Gamage DG, Riddell MA, Joshi R, Thankappan KR, Chow CK, Oldenburg B, et al. : Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: A cluster randomised controlled trial. PLOS Medicine 2020, 17(1):e1002997. doi: 10.1371/journal.pmed.1002997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.He J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, et al. : Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial. JAMA 2017, 318(11):1016–1025. doi: 10.1001/jama.2017.11358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Neupane D, McLachlan CS, Mishra SR, Olsen MH, Perry HB, Karki A, et al. : Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial. The Lancet Global health 2018, 6(1):e66–e73. doi: 10.1016/S2214-109X(17)30411-4 [DOI] [PubMed] [Google Scholar]
  • 28.Tam HL, Wong EML, Cheung K: Effectiveness of Educational Interventions on Adherence to Lifestyle Modifications Among Hypertensive Patients: An Integrative Review. International Journal of Environmental Research and Public Health 2020, 17(7):2513. doi: 10.3390/ijerph17072513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ozoemena EL, Iweama CN, Agbaje OS, Umoke PCI, Ene OC, Ofili PC, et al. : Effects of a health education intervention on hypertension-related knowledge, prevention and self-care practices in Nigerian retirees: a quasi-experimental study. Archives of Public Health 2019, 77(1):23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jolles EP, Clark AM, Braam B: Getting the message across: opportunities and obstacles in effective communication in hypertension care. Journal of hypertension 2012, 30(8):1500–1510. doi: 10.1097/HJH.0b013e32835476e1 [DOI] [PubMed] [Google Scholar]
  • 31.White ND, Lenz TL, Smith K: Tool guide for lifestyle behavior change in a cardiovascular risk reduction program. Psychology research and behavior management 2013, 6:55–63. doi: 10.2147/PRBM.S40490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Liu L, Qian X, Chen Z, He T: Health literacy and its effect on chronic disease prevention: evidence from China’s data. BMC Public Health 2020, 20(1):690. doi: 10.1186/s12889-020-08804-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Marasini B: Health System Development in Nepal. Journal of Nepal Medical Association 2020, 58(221). doi: 10.31729/jnma.4839 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Shen Y, Wang TT, Gao M, Hu K, Zhu XR, Zhang X, et al. : [Effectiveness evaluation of health belief model-based health education intervention for patients with hypertension in community settings]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2020, 54(2):155–159. doi: 10.3760/cma.j.issn.0253-9624.2020.02.008 [DOI] [PubMed] [Google Scholar]
  • 35.Stergiou GS, Palatini P, Modesti PA, Asayama K, Asmar R, Bilo G, et al. : Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. Journal of hypertension 2020, 38(7). [DOI] [PubMed] [Google Scholar]
  • 36.Woodhouse PR, Khaw KT, Plummer M: Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. Journal of hypertension 1993, 11(11):1267–1274. [PubMed] [Google Scholar]

Decision Letter 0

Yoshihiro Fukumoto

13 Aug 2021

PONE-D-21-20934

Effectiveness of community-based health education and home support program to reduce blood pressure among the patients with uncontrolled hypertension in Nepal: A cluster-randomized trial

PLOS ONE

Dear Dr. Khanal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 27 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors reported that multiple health education sessions complemented by frequent household visits by health volunteers can effectively improve knowledge on hypertension and reduce the blood pressure among uncontrolled hypertensive patients at community level in Nepal. This manuscript may be interesting. However, there are several concerns in this manuscript.

Major comments:

1) The most serious concern may be a small number of subjects as authors raised it in the section of limitation. The small sample size will lead a wrong conclusion.

2) In Tables 3 and 6, authors should not analyze data by adjusting for SBP and DBP simultaneously.

3) In Tables 3-5, how do authors deal with the use of antihypertensive medication, which may impact on systolic and diastolic blood pressures?

4) The section of “Results” is too long and redundant.

5) Authors should ask natives to edit English.

Minor comments:

1) Although systolic blood pressure and diastolic blood pressure were already abbreviated as SBP and DBP, authors were using systolic blood pressure and diastolic blood pressure without abbreviation again and again.

2) In the footnote of Table 1, Fischar exact test may be wrong. Fisher’s exact test may be correct. Authors should add the explanation in the section of data analysis.

3) In the section of result, Effectiveness of intervention: line 312; “After adjusting for” is correct. Line 316; “we adjusted for” is correct.

4) In the section of result, Sensitivity analysis: not “Odds Ratio” but “odds ratio.” Line 353; “After adjusting for” is correct.

5) In the section of Discussion, line 380: not “8.2m Hg” but “8.2mmHg”.

6) The journal names of the references should be accurately abbreviated.

Reviewer #2: Major comments:

This study was a research article which was showing that the multiple health education sessions can improve knowledge on hypertension and reduce the blood pressure among uncontrolled hypertensive patients. The concept of the present study was valuable but there are some concerns as described below.

1. As it was unclear the improvements of parameters such as SBP, DBP and the knowledge score after interventions, authors should better describe the change of parameters as “follow-up minus baseline”.

2. The authors didn’t satisfyingly describe why the multiple health education programs were effective to reduce blood pressure among uncontrolled hypertension patients. Authors should reveal that why systolic blood pressure was improved among uncontrolled hypertension patients after intervention, for example the reduction of salt, their physical activity or the antihypertensive drug adherence?

Minor comments:

1. Page 3; line 42-44: As the mean change in SBP calculated follow-up minus baseline, “-18.7mmHg vs. -11.2mmHg”, “-10.95mmHg vs. -5.53mmHg” are correct.

2. Page 5; line 58: not “10・8”but ”10.8”

3. Figure 1: The excluded numbers in participate are needed to add in figure 1 and the section of “participants’ flow”.

4. Page 19; Table 4: not “baseline and follow-up” but “follow-up minus baseline”, and authors should correct values on table 4 and manuscripts.

5. Page 23; line 376-382: not “6・47, 2・85” but “6.47, 2.85”, not “mm Hg” but “mmHg”.

Reviewer #3: A cluster-randomized controlled trial was conducted which aimed, primarily to compare the proportion of participants with controlled systolic blood pressure (SBP) between the intervention and control arms. The proportion with controlled SBP was significantly higher in the intervention arm compared to the control arm.

Minor revisions:

1- Line 115: Typographical error: Alpha

2- Line 251: Specify the descriptive statistics used to summarize the data.

3- Line 253: An underlying assumption of the chi-square test is independence of samples. The baseline and follow-up outcome variables are not independent; therefore, the chi-square test is inappropriate for comparing these outcomes.

4- Line 262: State the numbers of data points requiring imputation.

5- Table 1 Footnote:

a. Fisher’s is misspelled.

b. For clarity, associate double asterisks with the second comment.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Yoshihiro Fukumoto

31 Aug 2021

PONE-D-21-20934R1

Effectiveness of community-based health education and home support program to reduce blood pressure among the patients with uncontrolled hypertension in Nepal: A cluster-randomized trial

PLOS ONE

Dear Dr. Khanal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 15 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The revised manuscript has been much improved according to the reviewers' helpful comments.

This reviewer does not have any further comments.

Reviewer #2: Minor comments:

A few comments were not addressed.

1. Page 5; line 58: not “10・8” but ”10.8”

2. Page 24; line 392-398: not “6・47, 2・85” but “6.47, 2.85”

3. Page 24; line 393,394, 397, 398: not “mm-Hg” but “mmHg”.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Yoshihiro Fukumoto

27 Sep 2021

Effectiveness of community-based health education and home support program to reduce blood pressure among patients with uncontrolled hypertension in Nepal: A cluster-randomized trial

PONE-D-21-20934R2

Dear Dr. Khanal,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

Yoshihiro Fukumoto

4 Oct 2021

PONE-D-21-20934R2

Effectiveness of community-based health education and home support program to reduce blood pressure among patients with uncontrolled hypertension in Nepal: A cluster-randomized trial

Dear Dr. Khanal:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Syllabus for health education.

    (DOCX)

    S2 Table. Linear regression model for change in knowledge score.

    (DOCX)

    S3 Table. CONSORT extension for cluster trials 2010 checklist.

    (DOCX)

    S4 Table. Trial protocol.

    (DOC)

    S5 Table. Distribution of mean difference at 6-month follow-up SBP and DBP by gender, age, in both control and intervention group.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewer 1.docx

    Attachment

    Submitted filename: Respone to Reviewer 2.docx

    Data Availability Statement

    All data files are available from the Dryad repository, available at https://doi.org/10.5061/dryad.7h44j0zts.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES